Site Index

2014‑07‑02 I’ll Take Mine Rare
2014‑07‑07 Accelerated Aging
2014‑07‑11 Progression vs. Hardship
2014‑07‑16 Is There a Doctor in the House?
2014‑07‑20 Walking, Running, and Bicycling
2014‑07‑23 Bicycling with Ataxia
2014‑08‑01 This Is Exhausting
2014‑10‑31 The Unholy Trinity
2014‑10‑31 Tickler, Tickle Thyself
2014‑12‑19 Inflation (Rarity, Part Two)
2014‑12‑23 Terminology (SCA)
2015‑01‑23 Terminology (Causes, Symptoms)
2015‑06‑24 What Is Balance?
2015‑10‑30 Symptom? Disease? Disorder?
2015‑11‑14 Double Vision
2015‑11‑16 Playing the Piano
2015‑11‑23 Hear Me Play the Piano
2015‑12‑08 Prevalence and Incidence of Rare Diseases
2015‑12‑23 Rarity Again (Neurologists)
2016‑05‑05 Drug Repurposing
2016‑06‑16 Citalopram and SCA3
2016‑08‑29 Unchained Malady
2016‑09‑07 Muddled Thoughts on a Cure
2016‑10‑03 Stranger in a Strange Land
2016‑12‑12 What is BHV‑4157?
2017‑03‑09 Clearer Thoughts on a Cure
2017‑06‑22 Vision Correction and Proprioception
2017‑06‑24 Shut Up, Genes
2017‑07‑03 CRISPR and Crunchier
2017‑07‑11 Why I’m Skeptical of Trigriluzole for SCA3
2017‑07‑14 An Ounce of Prevention?
2017‑07‑20 Quel Che Sarà Sarà
2017‑08‑22 Stem Cell Terminology
2017‑09‑12 Can You Repeat That?
2017‑11‑01 How to Make a Treatment Seem Better Than It Is
2017‑11‑10 SCA Therapeutics Development
2017‑11‑20 FDA-Approved ASO Therapies

Interactive pages

2015‑12‑08 Prevalence and Incidence of Rare Diseases
2015‑12‑26 Prevalence of Ataxia
2017‑07‑14 Impact of SCA Prevention on SCA Prevalence